Nutex Health, Inc. financial data

Symbol
NUTX on Nasdaq
Location
6030 S. Rice Ave., Suite C, Houston, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
Clinigence Holdings, Inc. (to 3/31/2022), iGambit, Inc. (to 11/13/2019)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 165 % +1.86%
Quick Ratio 4.42 % -17.2%
Debt-to-equity 542 % +50.7%
Return On Equity -51.3 % -96.3%
Return On Assets -9.89 % -51.9%
Operating Margin -3.33 % +32.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.44M shares -99.2%
Common Stock, Shares, Outstanding 5.22M shares +16.6%
Entity Public Float 145M USD -86%
Common Stock, Value, Issued 5.22K USD +16.6%
Weighted Average Number of Shares Outstanding, Basic 5.1M shares +15%
Weighted Average Number of Shares Outstanding, Diluted 4.43M shares -99.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 292M USD +26%
General and Administrative Expense 37.7M USD +21.4%
Costs and Expenses 224M USD +5.01%
Operating Income (Loss) -9.73M USD +14.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -29.5M USD -10.9%
Income Tax Expense (Benefit) 2.87M USD
Net Income (Loss) Attributable to Parent -41.1M USD -42.2%
Earnings Per Share, Basic -1.85 USD/shares +15.1%
Earnings Per Share, Diluted -1.85 USD/shares +15.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.9M USD +74.9%
Accounts Receivable, after Allowance for Credit Loss, Current 62.7M USD +17.9%
Inventory, Net 2.26M USD -15.8%
Assets, Current 120M USD +33.3%
Operating Lease, Right-of-Use Asset 11.4M USD -31.5%
Intangible Assets, Net (Excluding Goodwill) 15.9M USD -26.7%
Goodwill 13.9M USD -22.4%
Assets 438M USD -8.58%
Accounts Payable, Current 10.3M USD -41.4%
Liabilities, Current 67.6M USD +0.43%
Deferred Income Tax Liabilities, Net 3.4M USD -59.9%
Operating Lease, Liability, Noncurrent 14.3M USD -9.87%
Liabilities 359M USD -4.28%
Retained Earnings (Accumulated Deficit) -419M USD -10.9%
Stockholders' Equity Attributable to Parent 60.4M USD -32.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 79.8M USD -24%
Liabilities and Equity 438M USD -8.58%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.05M USD +190%
Net Cash Provided by (Used in) Financing Activities 5.69M USD +93.1%
Net Cash Provided by (Used in) Investing Activities -733K USD +86.5%
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 5.22M shares -99.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 548K USD +27.3%
Deferred Tax Assets, Valuation Allowance 7.48M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 1.78 pure +2443%
Deferred Tax Assets, Gross 19.5M USD +117%
Payments to Acquire Property, Plant, and Equipment 3.07M USD +38131%
Property, Plant and Equipment, Gross 102M USD +0%
Operating Lease, Liability, Current 2.06M USD +31.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25%
Deferred Income Tax Expense (Benefit) -95.4K USD +89.5%
Deferred Tax Assets, Operating Loss Carryforwards 3.81M USD +123%
Additional Paid in Capital 479M USD +2.49%
Amortization of Intangible Assets 1.5M USD -6.25%
Depreciation, Depletion and Amortization 4.19M USD +4.82%
Interest Expense 17.6M USD +27.9%